| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $52,346 | +1,397 | +4.5% | $37.47 | 32,268 | 07 May 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | $166,014 | -1,397 | -4.3% | $118.84 | 30,871 | 07 May 2021 | Direct | F2 |
| transaction | XYL | Common Stock | Options Exercise | $24,310 | +503 | +1.6% | $48.33 | 31,374 | 07 May 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | $59,641 | -503 | -1.6% | $118.57 | 30,871 | 07 May 2021 | Direct | F3 |
| transaction | XYL | Common Stock | Options Exercise | $91,682 | +1,897 | +6.1% | $48.33 | 32,768 | 07 May 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | $225,404 | -1,897 | -5.8% | $118.82 | 30,871 | 07 May 2021 | Direct | F4 |
| transaction | XYL | Common Stock | Sale | $213,444 | -1,796 | -5.8% | $118.84 | 29,075 | 07 May 2021 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -1,397 | -100% | $0.000000* | 0 | 07 May 2021 | Common | 1,397 | $37.47 | Direct | F6 |
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -503 | -2.9% | $0.000000 | 17,103 | 07 May 2021 | Common | 503 | $48.33 | Direct | F6 |
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -1,897 | -11% | $0.000000 | 15,206 | 07 May 2021 | Common | 1,897 | $48.33 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F3 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F4 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F5 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.36. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F6 | These options are fully vested and exercisable. |